BGAM
CELG

Boussard & Gavaudan Asset Management’s Celgene Corp CELG Stock Holding History

Boussard & Gavaudan Asset Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-3,386
Closed -$292K – 108
2014
Q2 		$292K Buy
+3,386
New +$257K 0.15% 14
2014
Q1 		– Sell
-2,678
Closed -$226K – 132
2013
Q4 		$226K Buy
+2,678
New +$212K 0.16% 62

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Boussard & Gavaudan Asset Management's CELG Position: Q3 2014 in Review

Boussard & Gavaudan Asset Management sold out of Celgene Corp (CELG) in Q3 2014, closing a stake of 3,386 shares — an estimated $292K sold.

Boussard & Gavaudan Asset Management first reported a position in CELG in Q4 2013 and held it in 2 quarters. The position peaked at $292K in Q2 2014. 1,031 funds tracked by Wall St. Rank hold CELG as of Q3 2014.

  • Boussard & Gavaudan Asset Management reported no remaining Celgene Corp position as of Q3 2014 after selling out during the quarter.
  • Boussard & Gavaudan Asset Management sold 3,386 Celgene Corp shares in Q3 2014, an estimated $292K.
  • Boussard & Gavaudan Asset Management first reported a position in Celgene Corp in Q4 2013 and held it in 2 quarters.
  • Boussard & Gavaudan Asset Management's Celgene Corp position peaked at $292K in Q2 2014.
  • 1,031 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2014.

Based on Boussard & Gavaudan Asset Management's 13F filing for Q3 2014.